Raidium Expands AI Radiology Platform to U.S. Cancer Centers
PARIS & SAN FRANCISCO, July 16, 2026 Raidium has announced the U.S. launch of Raidium Read (R.Read), an AI-powered...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
PARIS & SAN FRANCISCO, July 16, 2026 Raidium has announced the U.S. launch of Raidium Read (R.Read), an AI-powered...
REDWOOD CITY, Calif., July 16, 2026 Trellis Bioscience has secured $9 million in Series C financing to accelerate the...
